Abstract Human chorionic gonadotropin (hCG) is a heterodimeric, placental glycoprotein hormone involved in the maintenance of the corpus luteum during the first trimester of pregnancy. Biologically active hCG has been successfully expressed in the yeast Pichia pastoris (phCG). In the context of structural studies and therapeutic applications of phCG, detailed information about its glycosylation pattern is a prerequisite. To this end N-glycans were released with peptide-N 4 -(N-acetyl-β-glucosaminyl)asparagine amidase F and fractionated via anion-exchange chromatography (Resource Q) yielding both neutral (80%) and charged, phosphate-containing (20%) high-mannosetype structures. Subfractionations were carried out via normal phase (Lichrosorb-NH 2 ) and high-pH anion-exchange (CarboPac PA-1) chromatography. Structural analyses of the released N-glycans were carried out by using HPLC profiling of fluorescent 2-aminobenzamide derivatives, MALDI-TOF mass spectrometry, and 500-MHz 1 H-NMR spectroscopy. Detailed neutral oligosaccharide structures, in the range of Man 8 GlcNAc 2 to Man 11 GlcNAc 2 including molecular isomers, could be established, and structures up to Man 15 GlcNAc 2 were indicated. Phosphatecontaining oligosaccharides ranged from Man 9 PGlcNAc 2 to Man 13 PGlcNAc 2 . Mannosyl O-glycans were not detected. Profiling studies carried out on different production batches showed that the oligosaccharide structures are similar, but their relative amounts varied with the culturing media.
-(N-acetyl-β-glucosaminyl) asparagine amidase F FPLC fast protein liquid chromatography 2AB 2-aminobenzamide MALDI-TOF-MS matrix-assisted laser desorption ionization time-of-flight mass spectrometry HPLC high-performance liquid chromatography HPAEC high-pH anion-exchange chromatography PAD pulsed amperometric detection TOCSY total correlation spectroscopy ROESY rotating-frame nuclear Overhauser enhancement spectroscopy WEFT water eliminated Fourier transform MLEV composite pulse devised by M. Levitt role during the first trimester of pregnancy. It indirectly stimulates the corpus luteum to produce progesterone until the placenta itself acquires the ability to produce this pregnancy-sustaining steroid [1] . Usually, hCG isolated from the urine of pregnant women is used in the in vitro fertilization technology as a therapeutic analogue of lutropin for the induction of final follicular maturation and ovulation in infertile women. Native hCG consists of two non-covalently associated subunits, denoted α and β, and is glycosylated for about 30%. The α-subunit (∼15 kDa), containing 92 amino acids, is N-glycosylated at Asn52 and Asn78, and the β-subunit (∼23 kDa), consisting of 145 amino acids, is N-glycosylated at Asn13 and Asn30 and O-glycosylated at Ser121, Ser127, Ser132, and Ser138. The distribution of the Nglycans on urinary hCG was found to be site-specific [2] [3] [4] : monosialylated monoantennary and disialylated diantennary structures, with Neu5Ac in (α2-3) linkage to Gal, were found at all N-glycosylation sites whereas monosialylated hybrid-type structures only occur at α-hCG Asn52 and (α1-6)-fucosylation only at β-hCG Asn13 and Asn30. Indications for the occurrence of trisialylated tri-and tri′-antennary glycans on β-hCG have also been reported [5] . Structural data for the O-glycosylation comprise mainly the conventional mono-and disialylated core 1-type structures, the disialyl-hexasaccharide (including core 2 type), and the sialylated disaccharide [6] [7] [8] . A random distribution of these O-glycans among the attachment sites has been suggested [9] . Over the years many studies have appeared demonstrating the crucial importance of the glycosylation of hCG for its biological functioning (for a review, see e.g., [10] ). In reaching conclusions, site-directed mutagenesis of specific (glycosylation) sites in urinary hCG applying different host cell systems played a major role.
In order to replace for pharmaceutical applications the urinary glycohormone by a recombinant variant, detailed attention has to be paid to the glycosylation patterns generated in relevant host cell systems. Expression of hCG in CHO cells shows the same mono-, di-, tri-, and tri′-antennary N-glycans as found for urinary hCG; Neu5Ac occurs in (α2-3) linkage to Gal. The O-glycans comprise mainly the convential saccharides (see above) [8, 11, 12] . CHO cells have also been used for generating 13 C/ 15 Nlabeled hCG for NMR studies [13] . Expression of hCG in baculovirus insect cell systems yields hCG which appears to have also oligomannose-type chains [14] [15] [16] . Furthermore, oligomannose-type chains were found on hCG expressed in Dictyostelium discoideum [17, 18] . Expression of hCG in malignant trophoblastic JAR cells yielded a β-subunit with predominantly endo-H-resistant N-glycans and an α-subunit with a more complicated array of endo-Hresistant and endo-H-sensitive (hybrid) N-glycans [19, 20] . Recombinant hCG from mouse C127 mammary tumor cells showed that, compared with urinary hCG, only the α-subunit has strongly deviating glycans; i.e., sialylated diantennary chains were suggested to be replaced by notspecified sialylated triantennary chains [21] .
In earlier studies it has been shown that the methylotrophic yeast Pichia pastoris allows an easy production of biologically active hCG [22, 23] . However, P. pastoris does not produce the typical oligomannose-, hybrid-and complex-type glycosylation patterns as generally found in mammalian cell systems. Several studies on other recombinant glycoproteins expressed in P. pastoris have shown that relatively small (compared with glycoproteins from other yeast species) (phosphorylated) high-mannose-type structures are present, generally containing 8 to 14 Man residues [24] [25] [26] [27] [28] . O-Mannosylation of proteins expressed in P. pastoris has also been reported (1-5 mannose residues) [29] [30] [31] [32] ; however, it occurs less frequently than N-glycosylation.
In the context of broader studies focused on the pharmaceutical use of P. pastoris expressed hCG (phCG) and on the use of P. pastoris cells to prepare 13 C/ 15 N-labeled phCG for three-dimensional studies of its structure in solution using NMR spectroscopy, a detailed glycan analysis of phCG was undertaken by mass spectrometry and NMR spectroscopy. In addition, attention was paid to possible changes in glycosylation pattern when changing the culturing conditions.
Materials and methods

Recombinant hCG expressed in Pichia pastoris (phCG)
The cloning, expression, and purification of biologically active phCG have been described previously [23] . Briefly, PCR-amplified hCG was cloned into a pPIC9k expression vector, and the best phCG-secreting clone was selected and grown in a 10 liter fermenter vessel. The secreted protein was purified from the culture supernatant and its biological activity determined by RIA. Batch I was produced exactly according to [23] ; ammonia was used as nitrogen source, and glycerol then methanol as carbon sources. Batch II was produced using FM22 medium (Invitrogen); ammonium sulfate was used as nitrogen source, and glycerol then methanol as carbon sources (to be published).
Monosaccharide analysis
Human phCG (400 μg) was desalted on a Pharmacia FPLC system using 5 HiTrap columns (5×5 ml) connected in series. The eluent consisted of 5 mM NH 4 HCO 3 and the fractionation was monitored by UV detection at 214 nm. The sample was lyophilized, and subjected to methanolysis (1.0 M methanolic HCl, 24 h, 85°C) followed by re-N-acetylation and trimethylsilylation [33] . The generated mixture of trimethylsilylated methyl glycosides was analyzed by GLC on an EC-1 column (30 m×0.32 mm; Alltech, Breda, The Netherlands), using a Chrompack CP9002 gas chromatograph (temperature program 140-240°C at 4°C/min) and flame-ionization detection.
Reduction and carboxymethylation
Human phCG was reduced and S-carboxymethylated according to procedures described before [21] . Briefly, phCG (12 mg) was dissolved in 6.5 ml 1 M Tris/HCl, pH 8.25, containing 6 M guanidinium-HCl, 1 mM EDTA, and 34 mM dithiothreitol; and the solution was kept for 2 h at 37°C. Then, iodoacetic acid (0.5 M in 0.5 M NaOH) was added to a final concentration of 68 mM, and the incubation was continued for 30 min in the darkness. After quenching the reaction by adding an excess of 2-mercaptoethanol, low-molecular-mass compounds were removed by using 5-kDa centrifugal concentrators, and the retentate was lyophilized. The chemical conversion was checked by 10% SDS-PAGE under reducing conditions.
Separation of the subunits
For the N-glycan profiling studies on the α-and β-subunits of the phCG batches I and II, prior to digestion with peptide-N 4 -(N-acetyl-β-glucosaminyl)asparagine amidase F (PNGase F; EC 3.5.1.52) (Roche Molecular Biochemicals, IN) and labeling with 2-aminobenzamide (2AB; Sigma), reduced and carboxymethylated phCG (2 mg) was separated into subunits on a Superdex G75 column (60×2.6 cm; Pharmacia, Uppsala, Sweden) using 50 mM NH 4 HCO 3 , pH 7.0, as eluent at a flow rate of 1 ml/min, monitored at 214 nm (Uvicord, LKB).
Release and isolation of N-glycans
Reduced and carboxymethylated phCG (batch I; ∼12 mg) was dissolved in 6 ml 20 mM NaH 2 PO 4 /Na 2 HPO 4 , pH 7.2, containing 10 mM EDTA, and digested with 8 U of PNGase F for 24 h at 37°C. The N-glycan pool was separated from the protein on a Superdex G75 column using the same conditions as described above. N-Deglycosylated phCG and the pool of N-glycans were then lyophilized.
FPLC fractionation
The pool of N-glycans was fractionated according to charge on a Resource Q anion-exchange column (1 ml, Pharmacia) at a flow rate of 1 ml/min [6] using a Pharmacia FPLC system. The elution, monitored by UV absorbance at 214 nm, was performed with 4 ml H 2 O, followed by a linear concentration gradient of 0-500 mM NaCl in 9 ml H 2 O. The fractions obtained were desalted on Carbograph extract-clean columns (Alltech) [34] , and lyophilized.
HPLC fractionation
The FPLC fractions were further fractionated on a Lichrosorb-NH 2 10 μm column (25×0.46 cm, Alltech) equipped with a LiChrospher Amino 5 μm guard column (7.5× 4.6 mm), using a Waters 600 HPLC system. Elutions were performed with a linear gradient of 30 mM K 2 HPO 4 / KH 2 PO 4 , pH 6.8, in acetonitrile at a flow rate of 1 ml/min, and monitored by UV absorbance at 206 nm. Relevant fractions were concentrated under a N 2 stream, desalted on Carbograph extract-clean columns (Alltech), and lyophilized.
HPAEC fractionation
HPAEC was performed on a Dionex DX 500 system equipped with a pulsed amperometric detection (PAD) unit. Neutral oligosaccharide fractions were subfractionated on a CarboPac PA-1 column (4×250 mm) using a gradient of 0.5 M sodium acetate/0.1 M NaOH (solvent B) in 0.1 M NaOH (solvent A) at a flow rate of 1 ml/min. The samples were loaded in 2% B-98% A, then the proportion of B was increased to 15% in 15 min, and then to 20% in 17 min, 33% in 6 min, 100% in 2 min. After 5 min of isocratic elution, the solvent system was put back to the initial conditions and equilibrated for 10 min. Fractions were immediately neutralized with 0.1 M HCl, desalted on Carbograph extractclean columns (Alltech), and lyophilized.
Modifications of the charged N-glycans
Mild acid treatment of glycans (1 μg) was carried out in 100 mM HCl (500 μl) for 30 min at 100°C [35] . Terminal phosphate groups attached to non-reducing ends of glycans were cleaved by treatment with 2 U alkaline phosphatase (Sigma, St. Louis, MO) in 50 mM citrate/phosphate buffer, pH 9, for 24 h at 37°C. 2AB-labeling of N-glycans and HPLC profiling 2AB-labeling of oligosaccharides was performed as described earlier [36, 37] . Briefly, about 1 nmol of dried glycans was incubated with 0.35 M 2-aminobenzamide/1 M sodium cyanoborohydride in acetic acid-dimethyl sulfoxide (3:7, v/v) (10 μl) for 2 h at 65°C. For the clean-up of the 2AB-labeled glycans, pre-treated (0.5% acetic acid for 24 h) quartz microfibre filters (QM-A, Whatman, England) were used. After applying the samples to a paper strip, the excess of reagents was removed by washing with 8×0.5 ml acetonitrile.
Glycans were eluted from the paper strip with 4×0.5 ml H 2 O, and, after lyophilization, residues were dissolved in 200 μl H 2 O.
Neutral N-glycan profiling was conducted by HPLC on a normal phase TSKgel Amide-80 column (4.6×250 mm; Tosoh BioScience, Germany), using a Waters 2690 XE Alliance System, equipped with a Waters 474 scanning fluorescence detector (1 exc . max =373 nm, 1 em . max =420 nm). For the elution, two solvent systems were used: solvent A, 50 mM ammonium formate, pH 4.4-acetonitrile (1:4, v/v); solvent B, 50 mM ammonium formate, pH 4.4. The linear gradients were comprised of 6.5 to 43.8% B in 100 min, followed by 43.8 to100% B over the next 3 min, then 100% B for 5 min before returning to the initial conditions in 5 min. The total run time at a flow rate of 0.8 ml/min was 140 min. Elution positions of the 2AB-labeled glycans were standardized in glucose units (GU) using a 2AB-labeled partial dextran hydrolysate as reference [38, 39] .
Charged N-glycan profiling was performed by HPLC on a weak anion-exchange Vydac 301 VHP5410 column (4.6× 100 mm; Grace Vydac, Hesperia, CA), using the same equipment as above. For the elution, two solvent systems were used: solvent A, 20% acetonitrile; solvent B, 0.5 M ammonium formate, pH 4.4-H 2 O-acetonitrile (5:3:2, v/v). After running 100% A for 5 min, charged N-glycans were eluted with a linear gradient of 0 to 100% B over 35 min. 100% B was maintained for 5 min before returning to the initial conditions in 1 min followed by a reequilibration step of 14 min. The total run time at a flow rate of 0.4 ml/min was 60 min.
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry MALDI-TOF mass spectra were recorded on a Voyager-DE mass spectrometer (Applied Biosystems) with implemented delayed extraction technique, equipped with a N 2 laser (337 nm, 3 ns pulse width). Spectra were recorded in a linear mode at an accelerating voltage of 24.5 kV using an extraction delay of 90 ns. For measurements in the positiveion mode, 0.5-μl samples were mixed in a 1:1 ratio on the target with 2,5-dihydroxybenzoic acid (10 mg/ml) dissolved in H 2 O-ethanol (9:1, v/v). For measurements in the negative-ion mode, 2′,4′,6′-trihydroxyacetophenone (10 mg/ml) dissolved in acetonitrile −20 mM ammonium citrate (1:1, v/v) was used as a matrix. In this case, the samples were dried under reduced pressure [40] .
1 H-NMR spectroscopy 1 H-NMR spectra were recorded on a Bruker AMX-500 spectrometer (Bijvoet Center, Department of NMR Spectroscopy, Utrecht University) at a probe temperature of 27°C [41] . HOD signal suppression was performed by applying a WEFT pulse sequence in 1D experiments [42] and by a pre-saturation of 1 s during the relaxation delay in 2D experiments. 2D-TOCSY spectra were recorded using MLEV-17 mixing sequence cycles of 50 ms, 2D-ROESY spectra were recorded with a mixing time of 300 ms, and 2D-NOESY spectra with a mixing time of 500 ms. NMR data sets were processed using in house developed software packages (J.A. van Kuik, Bijvoet Center, Department of Bio-Organic Chemistry, Utrecht University).
Results
Monosaccharide analysis [33] of phCG revealed a carbohydrate content of 30% (by mass) and the presence of mannose and N-acetylglucosamine in the molar ratio of 9:2. After reduction and carboxymethylation, phCG was digested with PNGase F, whereby SDS-PAGE was used to check the completeness of the de-N-glycosylation. The released pool of N-glycans, isolated via size-exclusion chromatography on Superdex G75, was fractionated by anion-exchange chromatography on Resource Q (FPLC), yielding three carbohydrate-containing fractions eluting at positions corresponding to neutral (Q0; 80%) and charged (Q1; 15% /Q2; 5%) compounds ( Fig. 1 ), as calculated from UV peak areas.
Neutral oligosaccharides
The pool of neutral N-glycans Q0 was analyzed in terms of molecular mass by MALDI-TOF-MS. In (Fig. 5a , Scheme 1, Table 1 ). The Man H-1 and H-2 chemical shifts are in agreement with literature data for this structure (see e.g., glycan QN2.4 of the human epidermal growth factor receptor [37] ). For comparison with 1 H-NMR data of the isomers missing the Man-D 1 or Man-D 3 residue, see [44] and [45] , respectively. For comparison with 1 H-NMR data of Man 9 GlcNAc 2 , containing Man-D 1 , Man-D 2 , and Man-D 3 , see [46] . The identified isomer, reflecting the usual first steps in trimming Glc 3 Man 9 GlcNAc 2 of Nglycans, has been reported to be an essential intermediate in yeast oligosaccharide processing [27, 47] .
Man 9 GlcNAc 2 pool
The structural-reporter-group region of the 1 H-NMR spectrum of subfraction Q0.M9 revealed the presence of two Man 9 GlcNAc 2 isomers, Q0.M9-1 and Q0.M9-2, with Q0. M9-1 as the major component (Fig. 5b, Scheme 1 , Table 1 ). The structure of Q0.M9-1 was identified as an extension of the Man 8 GlcNAc 2 structure with a Man-C′ residue, (α1-6)-linked with Man-4, thereby creating the typical yeast-processed Man 9 GlcNAc 2 structure. Compared with the 1 H-NMR spectrum of Q0.M8, the spectrum of Q0. M9 shows two additional structural-reporter-group signals, an H-1 signal at δ 4.927 and an H-2 signal at δ 3.99, both characteristic of terminal Man-C′ in a Man-C′-(α1-6)-Man-4 element [25, 43] Man-3 H-2 signal (5%) at δ 4.23 [41, 46, 48] , support the presence of structure Q0.M9-2, the convential precursor Man 9 GlcNAc 2 structure formed in the oligosaccharide processing of Glc 3 Man 9 GlcNAc 2 .
Man 10 GlcNAc 2 pool
The structural-reporter-group region of the 1 H-NMR spectrum of subfraction Q0.M10 indicated the presence of a mixture of Man 10 GlcNAc 2 isomers (Fig. 5c, Scheme 1 , Table 1 (Fig. 6a) , and three subfractions were isolated, Q0. M10-1, Q0.M10-2, and Q0.M10-3, which were checked by MALDI-TOF-MS to be pure Man 10 GlcNAc 2 isomers. Subfraction Q0.M10-3 did not contain sufficient material for NMR analysis.
The 1 H-NMR spectrum of HPAEC subfraction Q0.M10-1 revealed the presence of two isomeric structures, compounds Q0.M10-1a and Q0.M10-1b (Fig. 7a, Scheme 1 , Table 1 ), in agreement with the HPAEC peak pattern (Fig. 6a) H-NMR spectrum of HPAEC subfraction Q0.M10-2 is very similar to that of Q0.M9-1 (Fig. 7b, Scheme 1 , Table 1 
Man 11 GlcNAc 2 pool
The structural-reporter-group region of the 1 H-NMR spectrum of subfraction Q0.M11 indicated the presence of a mixture of Man 11 GlcNAc 2 isomers (Fig. 5d, Scheme 1 , Table 1 The Man 11 GlcNAc 2 pool was further fractionated by HPAEC (Fig. 6b) , and four subfractions were isolated, Q0. M11-1 (28%), Q0.M11-2 (31%), Q0.M11-3 (22%), and Q0.M11-4 (19%), which were checked by MALDI-TOF-MS to be pure Man 11 GlcNAc 2 isomers. The 1 H-NMR spectrum of HPAEC subfraction Q0.M11-1 is in accordance with structure Q0.M10-1b extended with Man-E 3 (Fig. 8a, Scheme 1, Table 1 ). However, one should keep in mind that for reasons outlined above for Q0.M10-1a, a definite choice for the extension of the additional Man residue, at Man-D 3 or at Man-D 1 , is not possible.
The 1 H-NMR spectrum of HPAEC subfraction Q0.M11-2 is in accordance with structure Q0.M10-1b extended with Man-D 5 or structure Q0.M10-2 extended with Man-D 4 (Man-C′ at δ 5.122 and Man-D 5 at δ 4.929) (Fig. 8b , Scheme 1, Table 1 ). The 1 H-NMR data are in good agreement with those reported earlier for Man 11 GlcNAc 1 compound IVb [25] . A possible reason for the unusual low intensity of Man-B H-1 (δ 5.145) has already been discussed for Q0.M10-1. The presence of the additional signal at δ 5.288 could correspond with a Man-D 1 H-1 signal, supporting a Man-(α1-2) extension at Man-D 1 instead of at Man-C′. Therefore, it is suggested that Q0. M11-2 contains besides Q0.M11-2 also this isomer.
The 1 H-NMR spectrum of HPAEC subfraction Q0.M11-3 is in accordance with structure Q0.M10-2 extended with Man-E 5 (Fig. 8c, Scheme 1 , Table 1 accordance with the increase in intensity observed for the H-1 signal corresponding with terminal Man-(α1-2) (δ 5.049) (see also compound IV-C in [25] ). The relatively high signal at δ 5.301 could reflect a Man-(α1-2) extension at Man-D 1 , as discussed for Q0.M11-2.
The 1 H-NMR spectrum of HPAEC subfraction Q0.M11-4 is in accordance with structure Q0.M10-2 extended with Man-E 6 (Fig. 8d, Scheme 1 , Table 1 ). The (α1-6)-region at δ 4.91 integrates to about three protons, reflecting the sequence Man-E 6 -(α1-6)-Man-D 5 -(α1-6)-Man-C′.
Charged oligosaccharides Q1
The pool of charged N-glycans Q1 was characterized in terms of molecular mass by MALDI-TOF-MS. In Fig. 2b its negative-ion mode mass spectrum is depicted, showing that the compounds range from Man 9 PGlcNAc 2 to Man 13-PGlcNAc 2 . Fractionation of FPLC fraction Q1 by normalphase HPLC on Lichrosorb-NH 2 gave rise to three subfractions denoted Q1-1 to Q1-3 (Fig. 4b ), which were analyzed by MALDI-TOF-MS to show that in terms of molecular mass Q1-1 contained Man 9-11 PGlcNAc 2 , Q1-2 Man 10-12 PGlcNAc 2 , and Q1-3 Man 12-13 PGlcNAc 2 , dem- onstrating a poor subfractionation. Subfractions Q1-1, Q1-2, and Q1-3 were further investigated by HPLC profiling, and Q1-1 and Q1-2 by 500-MHz 1 H NMR spectroscopy; subfraction Q1-3 did not contain sufficient material for NMR analysis.
Q1-1 pool (Man 9-11 PGlcNAc 2 )
The HPLC profile (weak anion-exchange Vydac 301 VHP5410 column) of the 2AB-derivatized pool of Nglycans Q1-1 revealed three peaks, A, B, and C, in the charged region of the chromatogram (Fig. 9a) . Treatment of subfraction Q1-1 with alkaline phosphatase, cleaving only terminal phosphate groups, led to the disappearance of peak C (Fig. 9b) , indicating that C corresponds to structures with a dicharged terminal phosphate group that have become neutral after digestion (P-Man-→ Man-) (data not shown). Positive-ion mode MALDI-TOF-MS of alkaline phosphatase-treated subfraction Q1-1 demonstrated the presence of neutral Man 9-11 GlcNAc 2 , in accordance with structures of Q1-1 before alkaline phosphatase treatment (Man 9-11 PGlcNAc 2 ). Treatment of subfraction Q1-1 with mild acid led to a shift of the position of peak A to that of peak C (Fig. 9c) , indicating that A corresponds to structures with an acid-labile monocharged diesterified phosphate group (Man-P-Man-→ P-Man-) [28] . Peak B seems to be a mixture of structures with terminal or diesterified phosphate groups, as deduced from the observation that peak B totally disappears only after both alkaline phosphatase and mild acid incubations. The presence of both diesterified and monoesterified phosphates in Q1-1 could be due to partial chemical decapping of phosphate during sample handling. Previously, the labilility of Man-P-Man-linkages during work-up procedures of S. cerevisiae mannoprotein has been mentioned [53] .
The structural-reporter-group region of the 1 H-NMR spectrum of subfraction Q1-1 (Fig. 10a, Table 1 ) is very similar to that of Man 9 GlcNAc 2 (Q0.M9-1; Fig. 5b ). The two additional "doublets" at δ 5.439 (J H−1,P =8.0 Hz) and 5.414 (J H−1,P =7.5 Hz) reflect the presence of at least two types of αMan-P-groups [54, 55] . In S. cerevisiae yeast glycoproteins, phosphate groups are attached to HO6 of Man-B and/or Man-C within the oligosaccharide chain [53] . As subfraction Q1-1 contains mainly Man 10 PGlcNAc 2 (MALDI-TOF-MS), and taking into account the various NMR data, it is suggested that subfraction Q1-1 contains, at any case, compounds Q0.M9-1 with Man-P-extensions. For The HPLC profiles of the 2AB-derivatized pools of Nglycans Q1-2 and Q1-3 were similar to that of Q1-1, and behaved in the same way when incubated with alkaline phosphatase or mild acid. Consequently, also subfractions Q1-2 and Q1-3 contain mixtures of structures with P-Man and Man-P-Man elements.
The structural-reporter-group region of the 1 H-NMR spectrum of subfraction Q1-2 (Fig. 10b, Table 1 ) shows a major characteristic doublet at δ 5.439 (J H−1,P =8.0 Hz) and two minor ones at δ 5.411 (J H−1,P =7.5 Hz) and δ 5.450 (J H−1,P = 8.0 Hz), in agreement with the presence of αMan-P-groups [54, 55] . As indicated by MALDI-TOF-MS, subfraction Q1-2 contains mainly Man 11 PGlcNAc 2 . In view of the broad H-1 signal at δ 4.912, also present in the 
Charged oligosaccharides Q2
The amount of the pool of charged N-glycans of Q2 was not sufficient for NMR studies or HPLC subfractionation. To gain some information about the components of the fraction, weak-anion HPLC profiling was conducted after 2AB derivatization. The chromatogram showed two peak areas A and B + C in the acidic region, with a relevant difference in retention time (Fig. 11 ). After treatment with alkaline phosphatase, the HPLC peak pattern of Q2 did not change, indicating the absence of P-Man-elements. Mild acid hydrolysis followed by an alkaline phosphatase digestion resulted in the complete disappearance of the charged components' peaks. Taking into account their retention times, it is speculated that peak A reflects glycans with one terminal Man-P-Man motif, and peaks B + C glycans with two terminal Man-P-Man motifs [28] .
Profiling studies of α-phCG and β-phCG from phGC batches I and II To compare the influence of the culturing medium on the Nglycosylation pattern of P. pastoris expressed hCG (phCG), two protocols were applied, yielding phCG batch I and phCG batch II. For batch I, ammonia was used as nitrogen source; for batch II, ammonium sulfate. Both batches were subjected to reduction, carboxymethylation, and separation of the α-and β-subunits on Superdex G75. MALDI-TOF-MS of α-phCG showed a molecular mass of 15 kDa, corresponding to about 11 kDa of protein backbone and 2 N-glycans of a mass in the range of 2 kDa each. For β-hCG these values are 19 kDa, about 15 kDa, and about 4 kDa reflecting 2 N-glycans, respectively.
The 4 samples were digested with PNGase F, and SDS-PAGE was used to verify the completeness of the de-Nglycosylation. The released free N-glycans of α-phCG I, β-phCG I, α-phCG II, and β-phCG II were converted into their 2AB-labeled derivatives, and analyzed by MALDI-TOF-MS and HPLC.
As is evident from Table 2 , the same neutral high mannosetype structures were present in both batches, but in different proportions. α-and β-phCG batch I contained higher amounts of Man 8 GlcNAc 2 and Man 9 GlcNAc 2 than α-and β-phCG batch II. The reverse held for Man 10 GlcNAc 2 and Man 11-GlcNAc 2 . In both batches, Man 12 GlcNAc 2 was a minor compound. Significant differences in size of the glycans on the subunits of a given batch were not observed. The profiles of the charged glycans showed identical patterns for the two batches and their subunits. It seems that the conditions used for the preparation of batch II induces more biosynthetic processing than those used for batch I.
Discussion
Structural analysis of the N-glycans of hCG expressed in the methylotrophic yeast Pichia pastoris has resulted in the identification of a pool of 80% neutral N-glycans and 20% charged (phosphorylated) N-glycans. Neutral N-glycans could be detected in the range of Man 8 GlcNAc 2 to Man 15 GlcNAc 2 . Based on MS, HPLC and NMR studies, for 10 components structures could be elucidated. Phosphorylated N-glycans were found in the range of Man 9 PGlcNAc 2 to Man 13 PGlcNAc 2 . Both Man-P-Man-and PMan-elements were detected, but probably P-Man-elements were introduced during work-up. The majority of the Nglycans contained 9 to 10 Man residues, independent on the chosen culturing process, whereby Man 9 GlcNAc 2 nearly only represents the typical yeast isomer. However, culturing conditions did influence the molar ratio within Man [8] [9] [10] [11] [12] GlcNAc 2 . It should be noted that previous NMR structural studies of yeast glycoprotein N-glycans were always carried out on Man x (P y )GlcNAc 1 compounds; in the present investigation NMR data of Man x (P y )GlcNAc 2 compounds are presented.
As urinary β-hCG contains O-linked glycans, and in view of the fact that P. pastoris-expressed glycoproteins can be O-mannosylated [29] [30] [31] [32] , β-phCG was checked for Omannosylation. Monosaccharide analysis performed on Ndeglycosylated phCG did not show any sugar constituent. In addition, MALDI-TOF-MS of β-phCG showed a molecular mass of 19 kDa, corresponding to about 15 kDa of protein backbone and 2 N-glycans of a mass in the range of 2 kDa each.
In conclusion, as expected, in the P. pastoris-expressed hCG (phCG), the glycosylation pattern is totally different from that of urinary hCG. However, earlier studies have already shown that, like urinary hCG, phCG is biologically active [23] . Both glycohormones show the same receptorbinding potential, and stimulate testosterone production by mouse Leydig cells and progesterone production by MA-10 cells. The present study on non-O-glycosylated phCG also shows that the O-glycosylation of β-hCG seems to have little influence on receptor binding and signal transduction, in accordance with earlier studies on urinary hCG [56] . In several studies, the importance of the N-glycosylation at Asn52 of urinary α-hCG for steroidogenic activity has been shown [56, 57] , and it has been postulated that the bulky and extended glycan at this site could have a function in inducing and stabilizing a conformational change in hCG upon binding to the receptor [58] . It is suggested that the high-mannose-type N-glycans on αAsn52 in phCG accomplish the same function.
